EU HEALTHCARE: HEALTHCARE: Sandoz (SDZSW: Baa2/BBB): 3Q24
Oct-30 07:01
Accelerating growth.
- Sales up +12% yoy for Q3 and +9% for the 9M period
- Led by Biosimilars +37% yoy with Generics +4%
- Raising guidance for Sales growth to henigh-single-digit
- Margin guidance maintained at “around 20%” which is up from 17.5% 1H24
- Aiming for NetDebt/Core EBITDA <2.0x in mid-term
- Calendar of biosimilar launches is healthy
Want to read more?
Find more articles and bullets on these widgets:
Historical bullets
EQUITIES: Biased Lower
Sep-30 07:00
Stoxx futures away from highs after initially benefitting from the stimulus-driven pre-holiday rally in Chinese equities. Futures now provide a negative lead ahead of the cash open,
- Euro Stoxx 50 futures -0.37%
- CAC 40 futures -0.36%
- FTSE MIB futures -0.66%
- FTSE 100 futures -0.33%
- SMI futures -0.55%
MNI: SWISS KOF SEP ECONOMIC BAROMETER 105.5
Sep-30 07:00
- MNI: SWISS KOF SEP ECONOMIC BAROMETER 105.5
GILTS: Futures Called Little Changed
Sep-30 06:57
Desks point to 98.79 for futures at the open, little changed vs. late Friday levels of 98.81.
Trending Top
Jan-30 21:43
Jan-30 21:11
